Table 1

Studies Reporting Discontinuation of Antidepressants

Study, Year (Design)DurationIntervention (Cessation Rate)Comparator (Cessation Rate)Risk Ratio (95% CI)
Depression only (anxiety comorbidities were excluded or not reported)
Klein et al,42 2017 (RCT)a6 monthsCBT + taper (34/85 = 40%)Maintenance antidepressant medication (n/a)n/a
Huijbers et al,34 2016 (Single arm from RCT)b6 months; after 6 monthsMBCT-TS (68/128 = 53%; 70/128 = 55%)n/an/a
Depression and/or anxiety disorders
Eveleigh,27 2015 (RCT)c12 monthsLetter to primary care clinician with recommendation + tapering advice (4/67 = 6%)Usual care (6/75 = 8%)0.75 (0.22–2.53); 1 study
Fava et al,15 1994 (RCT)20 weeksCBT + taper (20/21 = 95%)Clinical management + taper (20/22 = 91%)1.01 (0.89-1.15; I2 = 0%); 2 studies
Fava et al,32 1998 (RCT)20 weeksCBT + taper (20/23 = 87%)Clinical management + taper (20/22 = 91%)
Kuyken et al,16 2008 (RCT)c6 monthsMBCT-TS (46/61 = 75%)Maintenance antidepressant medication (n/a)n/a
Kuyken et al,17 2015 (RCT)d24 monthsMBCT-TS (124/176 = 70%)Maintenance antidepressant medication (n/a)n/a
Johnson et al,49 2012 (single-arm trial)PostinterventionGuided primary care clinician review (199/2,849 = 7%)n/an/a
  • CBT = cognitive behavioral therapy; ITT = intention to treat; MBCT = mindfulness-based cognitive therapy; MBCT-TS = mindfulness-based cognitive therapy with support to taper; n/a = not applicable; RCT = randomized controlled trial.

  • a A 3-arm RCT, but only 2 arms were relevant for this review; ITT analysis.

  • b A 2-arm RCT, but only 1 arm was relevant for this review (second arm: MBCT + maintenance antidepressant medication); ITT analysis.

  • c ITT analysis.

  • d Per-protocol analysis (completed 4 sessions of MBCT, 83% of those randomized to intervention arm).